SELLAS Life Sciences Grou... (SLS)
NASDAQ: SLS
· Real-Time Price · USD
1.63
0.03 (1.87%)
At close: May 16, 2025, 3:59 PM
1.64
0.92%
After-hours: May 16, 2025, 05:56 PM EDT
1.87% (1D)
| Bid | 1.63 |
| Market Cap | 162.14M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -27.13M |
| EPS (ttm) | -0.5 |
| PE Ratio (ttm) | -3.25 |
| Forward PE | -3.42 |
| Analyst | n/a |
| Ask | 1.66 |
| Volume | 2,668,113 |
| Avg. Volume (20D) | 1,463,116 |
| Open | 1.66 |
| Previous Close | 1.60 |
| Day's Range | 1.58 - 1.68 |
| 52-Week Range | 0.77 - 1.85 |
| Beta | 2.35 |
10 months ago
+4.59%
SELLAS Life Sciences Group shares are trading high...
Unlock content with
Pro Subscription
10 months ago
-0.82%
SELLAS Life Sciences shares are trading higher after the company was granted FDA Rare Pediatric Disease Designation for its SLS009 CDK9 inhibitor for the treatment of pediatric acute lymphoblastic leukemia, making it eligible for a priority review voucher worth over $100 million upon approval.
